患有炎症性肠病的患者心血管风险 - 内皮功能障碍的作用
Maria A Livzan1, Galiya R Bikbavova2, Natalya S Lisyutenko2
1Department of Faculty Therapy, Omsk State Medical University, 644099 Omsk, Russia.
Diagnostics (Basel, Switzerland)
|August 29, 2024
概括
炎症性肠病 (IBD) 增加了心血管疾病 (CVD) 的风险. 内皮功能障碍和肠血管屏障问题是将IBD与心血管疾病发展联系起来的关键机制.
科学领域:
- 胃肠病学和心脏病学
- 慢性炎症疾病的病理生理学
背景情况:
- 炎症性肠病 (IBD) 与心血管疾病 (CVD) 的更高风险有关,但根本机制尚未完全理解.
- IBD患者的心血管病理仍未得到充分研究,心血管事件和IBD之间没有明确确确定的直接联系.
- 关键的促成因素包括炎症,肠道微生物群的改变,内皮功能障碍,血栓性和增加屏障透性.
研究的目的:
- 审查驱动IBD内皮功能障碍的机制.
- 在IBD的心血管表现中探索肠血管屏障结构和功能障碍.
主要方法:
- 文献综述侧重于IBD,内皮功能和心血管健康之间的相互作用.
- 对有关IBD相关心脏病的炎症,肠道微生物群和屏障完整性的现有研究进行分析.
主要成果:
- 内皮功能障碍是IBD和动脉样硬化心血管疾病的共同致病因子.
- 这种功能障碍是IBD患者心血管病理的发展和进展的关键驱动因素.
- 肠血管屏障的破坏是IBD心血管并发症的组成部分.
结论:
- 内皮功能障碍和肠血管屏障受损是IBD心血管表现的核心.
- 了解这些机制对于控制IBD患者心血管疾病风险至关重要.
- 进一步的研究是有必要的,以建立直接联系和开发有针对性的干预措施.
相关概念视频
Inflammatory Bowel Disease I: Ulcerative Colitis
159
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
159
Inflammatory Bowel Disease II: Crohn's Disease
205
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
205
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
328
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
328
Chronic Bowel Disorders: Introduction
414
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
414
Inflammatory Bowel Disease IV: Pharmacological Management
122
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
122
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
145
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
145


